M. Abe

发表

Association between chronic kidney disease and the cognitive function in subjects without overt dementia .

M. Mifune, Hiroyuki Ito, S. Antoku, 2017, Clinical nephrology.

Non-alcoholic fatty liver disease is an independent predictor for macroangiopathy in Japanese type 2 diabetic patients: a cross-sectional study.

M. Mifune, Hiroyuki Ito, S. Antoku, 2012, Internal medicine.

The Prevalence of the Risk Factors for Atherosclerosis among Type 2 Diabetic Patients Is Greater in the Progressive Stages of Chronic Kidney Disease

M. Mifune, Hiroyuki Ito, S. Antoku, 2013, Nephron Extra.

Comparison of the Renoprotective Effect of Febuxostat for the Treatment of Hyperuricemia between Patients with and without Type 2 Diabetes Mellitus: A Retrospective Observational Study

M. Mifune, Hiroyuki Ito, S. Antoku, 2016, Internal medicine.

Comparison of the antidiabetic effects of linagliptin among groups with a normal renal function and a mild or severe renal impairment – retrospective observation study of Japanese patients with type 2 diabetes mellitus

M. Mifune, Hiroyuki Ito, S. Antoku, 2015, Expert opinion on pharmacotherapy.

Secular Trends in the Clinical Characteristics of Type 2 Diabetic Patients With Severe Hypoglycemia Between 2008 and 2013

M. Mifune, Hiroyuki Ito, S. Antoku, 2016, Journal of clinical medicine research.

Hypoglycemia observed during continuous glucose monitoring in patients with type 2 diabetes mellitus treated by subcutaneous insulin injection.

M. Mifune, Hiroyuki Ito, S. Antoku, 2013, Diabetes technology & therapeutics.

Relationships between the duration of illness and the current status of diabetes in elderly patients with type 2 diabetes mellitus

M. Mifune, Hiroyuki Ito, S. Antoku, 2017, Geriatrics & gerontology international.

N‐terminal fragment of pro‐brain natriuretic peptide (NT‐proBNP) for predicting silent myocardial ischaemia in type 2 diabetes mellitus independent of microalbuminuria

M. Abe, Shuzo Kobayashi, K. Hamano, 2010, Diabetes/metabolism research and reviews.

Anagliptin in the treatment of type 2 diabetes: safety, efficacy, and patient acceptability

Hiroyuki Ito, Shinya Nishio, M. Abe, 2015, Diabetes, metabolic syndrome and obesity : targets and therapy.